When Host Cell Protein analysis 2D gel Western blot is not enough | Problematic HCPs | PLBL2

Rejected by the FDA: 2D gel Western blot was not enough.
One of our clients was forced to put their Phase 3 clinical trial on hold. Their impurity risk assessment was not satisfactory to the FDA.
Watch this video to learn how their drug was approved for Phase 3.